These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 793304)

  • 1. A double-blind trial of baclofen against placebo in the treatment of schizophrenia.
    Gulmann NC; Bahr B; Andersen B; Eliassen HM
    Acta Psychiatr Scand; 1976 Oct; 54(4):287-93. PubMed ID: 793304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia.
    Korsgaard S
    Acta Psychiatr Scand; 1976 Jul; 54(1):17-24. PubMed ID: 782159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB; Nasrallah H; Carman J; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1977 Mar; 134(3):318-20. PubMed ID: 320885
    [No Abstract]   [Full Text] [Related]  

  • 4. Baclofen in the treatment of tardive dyskinesia.
    Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G
    Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of baclofen in children with cerebral palsy.
    Milla PJ; Jackson AD
    J Int Med Res; 1977; 5(6):398-404. PubMed ID: 338390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonazepam, baclofen and placebo in the treatment of spasticity.
    Cendrowski W; Sobczyk W
    Eur Neurol; 1977; 16(1-6):257-62. PubMed ID: 354938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baclofen (para-chlorphenyl-GABA) in schizophrenia.
    Beckmann H; Frische M; Rüther E; Zimmer R
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jan; 10(1):26-31. PubMed ID: 329292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of baclofen on tardive dyskinesia.
    Gerlach J; Rye T; Kristjansen P
    Psychopharmacology (Berl); 1978 Mar; 56(2):145-51. PubMed ID: 417365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Baclofen in schizophrenia.
    Simpson GM; Branchey MH; Shrivastava RK
    Lancet; 1976 May; 1(7966):966-7. PubMed ID: 57370
    [No Abstract]   [Full Text] [Related]  

  • 10. The immediate effects of chlorpromazine in newly admitted schizophrenic patients.
    Hamill WT; Fontana AF
    Am J Psychiatry; 1975 Oct; 132(10):1023-6. PubMed ID: 1101707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baclofen in spasticity.
    Lancet; 1977 Sep; 2(8038):594-5. PubMed ID: 71406
    [No Abstract]   [Full Text] [Related]  

  • 12. Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.
    Sachais BA; Logue JN; Carey MS
    Arch Neurol; 1977 Jul; 34(7):422-8. PubMed ID: 327987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Bacloffen in schizophrenia.
    Davis KL; Hollister LE; Berger PA
    Lancet; 1976 Jun; 1(7971):1245. PubMed ID: 58291
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study.
    Duncan GW; Shahani BT; Young RR
    Neurology; 1976 May; 26(5):441-6. PubMed ID: 772461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study.
    Feldman RG; Kelly-Hayes M; Conomy JP; Foley JM
    Neurology; 1978 Nov; 28(11):1094-8. PubMed ID: 362234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baclofen trial in six myotonic dystrophy patients.
    Guilleminault C; Flagg WH; Coburn SC; Dement WC
    Acta Neurol Scand; 1978 Mar; 57(3):232-8. PubMed ID: 352086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
    Johnstone EC; Crow TJ; Frith CD; Carney MW; Price JS
    Lancet; 1978 Apr; 1(8069):848-51. PubMed ID: 76797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
    Shopsin B; Klein H; Aaronsom M; Collora M
    Arch Gen Psychiatry; 1979 Jun; 36(6):657-64. PubMed ID: 375865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-methyldopa-chlorpromazine combination in schizophrenic patients.
    Chouinard G; Annable L
    Neuropsychobiology; 1976; 2(2-3):118-26. PubMed ID: 796755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind trial with the antispasticity drug Lioresal in 15 paraplegics with upper neuron lesions.
    Haubensak K
    Urol Int; 1977; 32(2-3):198-201. PubMed ID: 333693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.